Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Issuers

IPT: IQVIA E1.45bn sr 5NC2 2.00-2.25%, 8NC3 2.50%a, pxg tomorrow

HYC European Market: Deal Flow - General

IQVIA Inc (IQV) EUR1.45bn 144A/Reg S sr notes 2-part. Existing Ba3/BB. Via JPM (sole physical books, B&D)/Barc/BofA/GS/HSBC/WFS joint books, Citi, FITB, PNC, Mizuho, MUFG, TD, TSI, BBVA, BNPP, Huntington, RBC, Siebert Willliams as co-managers. No reg rights. List ISE. NY law.

   - EUR TBA (minimum EUR400m) due 2026 (5y). NC2 (MWC B+50bp) (50%,25%,par). Equity claw: 2y 40. IPT: 2.00%-2.25%.

   - EUR TBA due 2029 (8y). NC3 (MWC B+50bp) (50%,25%,par). Equity claw: 3y 40%. IPT: 2.50% area.

Did global investor call at 1pm UKT today (virtual 1x1 meetings also available today). Pricing tomorrow (02/17). UOP: redeem its EUR1.425bn 3.25% sr notes due 03/15/25 (callable at 100.813 on 03/15/21). Biz: leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. HQ: Durham, NC and Danbury, CT.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.